T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment
Authors
Keywords
Acute myeloid leukemia (AML), T cell exhaustion, PD-1, Immune checkpoint molecules, Cancer immunotherapy
Journal
Journal of Hematology & Oncology
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-07-29
DOI
10.1186/s13045-015-0189-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunotherapy for Acute Myeloid Leukemia
- (2015) Felix S. Lichtenegger et al. SEMINARS IN HEMATOLOGY
- Chemotherapy-induced augmentation of T cells expressing inhibitory receptors is reversed by treatment with lenalidomide in chronic lymphocytic leukemia
- (2014) F. J. Gassner et al. HAEMATOLOGICA
- Molecular Basis of the Dual Functions of 2B4 (CD244)
- (2014) L. K. Chlewicki et al. JOURNAL OF IMMUNOLOGY
- The targeting of immunosuppressive mechanisms in hematological malignancies
- (2014) M H Andersen LEUKEMIA
- Impaired NK cells and increased T regulatory cell numbers during cytotoxic maintenance therapy in AML
- (2014) Felix S. Lichtenegger et al. LEUKEMIA RESEARCH
- T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia
- (2013) A. Mardiros et al. BLOOD
- CD33 target validation and sustained depletion of AML blasts in long-term cultures by the bispecific T-cell-engaging antibody AMG 330
- (2013) C. Krupka et al. BLOOD
- CMV-specific CD8+ T-cell function is not impaired in chronic lymphocytic leukemia
- (2013) G. D. te Raa et al. BLOOD
- Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML
- (2013) G. S. Laszlo et al. BLOOD
- The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia
- (2013) D. Brusa et al. HAEMATOLOGICA
- CD4+T-cell inhibitory ligands: a tool for characterizing dysfunctional CD4+T cells during chronic infection
- (2013) Courtney Dow et al. IMMUNOLOGY
- The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies
- (2013) Li Shi et al. Journal of Hematology & Oncology
- Redirection of T cells with a first fully humanized bispecific CD33–CD3 antibody efficiently eliminates AML blasts without harming hematopoietic stem cells
- (2013) C Arndt et al. LEUKEMIA
- Persistence and Efficacy of Second Generation CAR T Cell Against the LeY Antigen in Acute Myeloid Leukemia
- (2013) David S. Ritchie et al. MOLECULAR THERAPY
- Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia
- (2013) Lisa Christiansson et al. PLoS One
- Anti-leukemia T cells in AML
- (2013) Anne Flörcken et al. Human Vaccines & Immunotherapeutics
- Inhibitory Receptor Expression Depends More Dominantly on Differentiation and Activation than “Exhaustion” of Human CD8 T Cells
- (2013) Amandine Legat et al. Frontiers in Immunology
- Disease-stabilizing treatment with all-trans retinoic acid and valproic acid in acute myeloid leukemia: Serum hsp70 and hsp90 levels and serum cytokine profiles are determined by the disease, patient age, and anti-leukemic treatment
- (2012) Hanne Fredly et al. AMERICAN JOURNAL OF HEMATOLOGY
- T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production
- (2012) J. C. Riches et al. BLOOD
- Current strategies in immunotherapy for acute myeloid leukemia
- (2012) Felix S Lichtenegger et al. Immunotherapy
- Functional Exhaustion of CD4+ T Lymphocytes during Primary Cytomegalovirus Infection
- (2012) P. Antoine et al. JOURNAL OF IMMUNOLOGY
- Natural killer cell immune escape in acute myeloid leukemia
- (2012) E Lion et al. LEUKEMIA
- T lymphocytes can be effectively recruited for ex vivo and in vivo lysis of AML blasts by a novel CD33/CD3-bispecific BiTE antibody construct
- (2012) M Aigner et al. LEUKEMIA
- CD160 and PD-1 Co-Expression on HIV-Specific CD8 T Cells Defines a Subset with Advanced Dysfunction
- (2012) Yoav Peretz et al. PLoS Pathogens
- Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia
- (2011) Q. Zhou et al. BLOOD
- Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection
- (2011) T. Yamamoto et al. BLOOD
- PD-1/PD-L1 Interactions Contribute to Functional T-Cell Impairment in Patients Who Relapse with Cancer After Allogeneic Stem Cell Transplantation
- (2011) W. J. Norde et al. CANCER RESEARCH
- Expansion of a CD8+PD-1+ Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD4:CD8 Ratios and Disease Progression
- (2011) C. Nunes et al. CLINICAL CANCER RESEARCH
- Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients
- (2011) Lukas Baitsch et al. JOURNAL OF CLINICAL INVESTIGATION
- T cell exhaustion
- (2011) E John Wherry NATURE IMMUNOLOGY
- Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia
- (2010) S. M. Kornblau et al. BLOOD
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients
- (2010) Julien Fourcade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Role of antigen persistence and dose for CD4+ T-cell exhaustion and recovery
- (2010) S. Han et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts
- (2009) R. Le Dieu et al. BLOOD
- Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression
- (2009) S. Mumprecht et al. BLOOD
- Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
- (2009) M. Ahmadzadeh et al. BLOOD
- Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies
- (2008) R. Berger et al. CLINICAL CANCER RESEARCH
- Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection
- (2008) R. Brad Jones et al. JOURNAL OF EXPERIMENTAL MEDICINE
- PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients
- (2008) T Kozako et al. LEUKEMIA
- CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator
- (2008) Guifang Cai et al. NATURE IMMUNOLOGY
- Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
- (2008) Shawn D Blackburn et al. NATURE IMMUNOLOGY
- Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people
- (2008) Sven Koch et al. Immunity & Ageing
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search